Capsule Summary Slidesets

Share

Program Content

Activities

  • JAK-POT
    JAK-POT: Real-World Risk of Treatment Discontinuation Across 17 International Registers of Patients With Rheumatoid Arthritis
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 01, 2020

    Expires: June 30, 2021

  • Risk of HZ in RA Patients
    RABBIT: Risk of Herpes Zoster Stratified by DMARD Type Among Patients With Rheumatoid Arthritis
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 01, 2020

    Expires: June 30, 2021

  • VTE: Tofacitinib, Baricitinib
    WHO VigiBase Analysis: Thromboembolic Safety of Tofacitinib, Baricitinib in Rheumatoid Arthritis
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 01, 2020

    Expires: June 30, 2021

  • Upadacitinib Infections
    Infection Incidence With Upadacitinib in Patients With Rheumatoid Arthritis
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 07, 2020

    Expires: July 06, 2021

  • FINCH 1 Wk 52
    FINCH 1: 52-Wk Results of Filgotinib in Patients With Rheumatoid Arthritis With Inadequate Response to Methotrexate
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 13, 2020

    Expires: July 12, 2021

  • Dutch Biologic Monitor
    Dutch Biologic Monitor: Fatigue Among Biologic Recipients Across a Range of Immune-Mediated Inflammatory Diseases
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 13, 2020

    Expires: August 12, 2021

  • SRQ
    SRQ: VTE Risk Increases Alongside Disease Activity Among Swedish Patients With Rheumatoid Arthritis
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 13, 2020

    Expires: August 12, 2021

  • SELECT-CHOICE
    SELECT-CHOICE: Upadacitinib vs Abatacept in Patients With Rheumatoid Arthritis With Inadequate Response or Intolerance to bDMARDs
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 17, 2020

    Expires: August 16, 2021

Provided by

ProCE Banner

Supporters

AbbVie Inc.

Gilead Sciences, Inc.